Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Innovative Medical
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Study participants must have a cataract for which phacoemulsification extraction and posterior IOL implantation has been planned in at least one eye.
Study participants should be capable of achieving better than 20/30 Snellen best corrected distance vision after cataract extraction and IOL implantation.
The surgeon may use the Mento Potential Acuity Meter (PAM)laser interferometer, McIntyre Pinhole, or his/her judgement to estimate the patient's potential acuity.
You may not be if
Concurrent participation or participation in the last 30 days in other clinical trials.
Known steroid IOP responder.
Taking medications that may affect vision, IOP, or ease of cataract surgery (e.g. Flomax, Glaucoma medications, etc.).
Acute or chronic disease or illness that would increase risk or confound study results(e.g. uncontrolled diabetes mellitus, immunocompromised, etc.).
Uncontrolled systemic or ocular disease.
Corneal abnormalities (e.g. stromal, epithelial, or endothelial dystrophies)
Pseudoexfoliation.
Ocular hypertension (\>or =20hg) or glaucomatous changes in the optic nerve.
